Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.
about
Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinationsEnhanced glucose control for preventing and treating diabetic neuropathyAcarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomesGlycosylated hemoglobin in relationship to cardiovascular outcomes and death in patients with type 2 diabetes: a systematic review and meta-analysisRole of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetesDoes tight control of systemic factors help in the management of diabetic retinopathy?The Effect of Bariatric Surgery on Diabetic Retinopathy: Good, Bad, or Both?Aryl hydrocarbon receptor is activated by glucose and regulates the thrombospondin-1 gene promoter in endothelial cellsAn exploration of barriers to insulin initiation for physicians in Japan: findings from the Diabetes Attitudes, Wishes And Needs (DAWN) JAPAN studyChanging illness perceptions in patients with poorly controlled type 2 diabetes, a randomised controlled trial of a family-based intervention: protocol and pilot study.Actos Now for the prevention of diabetes (ACT NOW) study.Replacement of neutral protamine Hagedorn insulin with the long-acting insulin analogue, detemir, improves glycemic control without weight gain in basal-bolus insulin therapy in Japanese patients with type 1 diabetes.Challenges in achieving optimal glycemic control in type 2 diabetes patients with declining renal function: The Southeast Asia perspectiveThe natural course of microalbuminuria among African Americans with type 2 diabetes: a 3-year study.Effects of insulin changes on quality of life and glycemic control in Japanese patients with type 2 diabetes mellitus: The insulin-changing study intending to gain patients' insights into insulin treatment with patient-reported health outcomes in acCerebral microvascular disease predicts renal failure in type 2 diabetes.Dose Modification of Antidiabetic Agents in Patients with Type 2 Diabetes Mellitus and Heart Failure.Test-retest reliability of a continuous glucose monitoring system in individuals with type 2 diabetesCardiac autonomic dysfunction in type 2 diabetes - effect of hyperglycemia and disease duration.Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trialsDiabetic neuropathy: clinical manifestations and current treatments.The role of TLR2 and 4-mediated inflammatory pathways in endothelial cells exposed to high glucose.Prediction of the risk to develop diabetes-related late complications by means of the glucose pentagon model: analysis of data from the Juvenile Diabetes Research Foundation continuous glucose monitoring study.Effects of twice-daily injections of premixed insulin analog on glycemic control in type 2 diabetic patientsClinical evaluation of Dyslipidemia among type II diabetic patients at Public hospital Penang, Malaysia.Clinical characteristics of patients with type 2 diabetes mellitus at the time of insulin initiation: INSTIGATE observational study in Spain.Rates and risk of hospitalisation among patients with type 2 diabetes: retrospective cohort study using the UK General Practice Research Database linked to English Hospital Episode Statistics.Are concomitant treatments confounding factors in randomized controlled trials on intensive blood-glucose control in type 2 diabetes? a systematic review.Long-term insulin glargine therapy in type 2 diabetes mellitus: a focus on cardiovascular outcomes.Sodium glucose co-transport 2 inhibitors in the treatment of type 2 diabetes mellitus: a meta-analysis of randomized double-blind controlled trialsHypoglycaemic events in patients with type 2 diabetes in the United Kingdom: associations with patient-reported outcomes and self-reported HbA1cKnockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization.The cost of major comorbidity in people with diabetes mellitusRetrospective analysis on the efficacy, safety and treatment failure group of sitagliptin for mean 10-month durationObservation on renal outcomes in the Veterans Affairs Diabetes TrialPerilipin 5 regulates islet lipid metabolism and insulin secretion in a cAMP-dependent manner: implication of its role in the postprandial insulin secretion.First insulinization with basal insulin in patients with Type 2 diabetes in a real-world setting in Asia.Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: prevalence of and risk factors for diabetes mellitus in CKD in the Kidney Early Evaluation Program (KEEP)Metabolic memory and individual treatment aims in type 2 diabetes--outcome-lessons learned from large clinical trials.HbA1c below 7% as the goal of glucose control fails to maximize the cardiovascular benefits: a meta-analysis
P2860
Q22241134-FEDD0ABB-C28B-4D59-B3CC-D5854FA286B1Q24202790-FE2A54B5-51B9-40BB-A487-5F8AFF271416Q26778095-5402D149-A0D9-4D5A-A483-2071F8832284Q26860467-75C0D511-3CF9-486F-A5ED-56315E35BF27Q27004274-F70075FA-62AE-46BA-A346-F6CEB3398EA8Q28074223-59E7EF36-37E7-409B-916E-D320550F515AQ28075888-578A1FAF-7376-4617-AB6C-5B3D538E0925Q28390982-FFBB161A-B35B-4C00-ACB4-15C7AE0AA710Q28728439-72A479DC-E460-4D61-B655-80C63C48E7BBQ33289137-DF0A78A0-003E-43F2-8E21-5E3460DFA5C1Q33488336-3879C566-4045-4AB3-9417-211553FC3777Q33558415-7537EC80-15E4-4B21-8AC8-00A529CDD082Q33587783-D98B78BD-B15B-4361-BF70-77635662ECF1Q33588129-8A0C411C-C276-4232-9AFD-0A65778B3D74Q33607730-AF790089-6E11-4A35-88B8-60E91B654D58Q33702434-CC4E06BA-BA01-4017-9F7B-37D868C921DCQ33815573-5B0B467D-664F-4859-B6BA-A46C3DB1398CQ33975185-E4F71138-7470-41F4-B036-25BE13C20901Q34018512-6A27295D-7B1F-46AF-9132-DAE2594A6636Q34083400-9477D018-6C8D-4407-B822-BF7A3130EDFAQ34275990-3AC8DC0E-5C05-40B1-91DE-AF46A48F8311Q34323203-370DAD90-C90D-4A01-91A8-3A5408D42D63Q34329297-B4A258ED-F519-4F19-A8EE-36A303043696Q34373342-7B3A1312-B275-45D7-B978-3E5B096BFDA7Q34410378-79BC0805-EC5E-4FFD-B1C2-5AA21503BE55Q34411776-0F81762E-B7B1-479B-9892-3872AE8EBD9BQ34804878-27731484-2630-4C92-934C-93DC09018CE0Q35042647-39507BC1-5CAD-4FFA-B75E-1EE240EEC08BQ35044151-C9D972A2-1F9E-42FD-96BB-5E29E1C31D03Q35068181-F1A8FC7D-8039-411B-A1AD-F761E4748D9EQ35071447-E6789E8A-02C1-4434-BA29-1A449B8D4C05Q35095572-E9D23532-E2B9-4D6C-B407-ACAD3D3CA5D3Q35099421-E3C298C6-A599-4B4B-8959-F5AE0F85527DQ35110343-B514F21D-627F-4189-9851-7931A96B8C36Q35179862-23E9B588-2B57-438A-857E-12718816DC49Q35220582-225434E8-9D67-4860-B59A-534A34E187E9Q35228491-A8CD5152-F2F1-4D03-AB06-3946D7042510Q35612606-F09E43A0-BAC8-4AE6-8FAD-6CC98240EC49Q35760316-FB03A3A5-C57F-4E23-9543-40CBE7D07DFCQ35782729-B441D6B6-9D4E-4544-80BB-73E6159C3443
P2860
Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Long-term results of the Kumam ...... l in type 2 diabetic patients.
@en
Long-term results of the Kumam ...... l in type 2 diabetic patients.
@nl
type
label
Long-term results of the Kumam ...... l in type 2 diabetic patients.
@en
Long-term results of the Kumam ...... l in type 2 diabetic patients.
@nl
prefLabel
Long-term results of the Kumam ...... l in type 2 diabetic patients.
@en
Long-term results of the Kumam ...... l in type 2 diabetic patients.
@nl
P2093
P1433
P1476
Long-term results of the Kumam ...... l in type 2 diabetic patients.
@en
P2093
P407
P478
23 Suppl 2
P577
2000-04-01T00:00:00Z